To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Premedication with intranasal dexmedetomidine in TKA under spinal anaesthesia (TKADEX)

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2025

Premedication with intranasal dexmedetomidine in TKA under spinal anaesthesia (TKADEX)

Vol: 307| Issue: 6| Number:19| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Premedication with intranasal dexmedetomidine in patients undergoing total knee arthroplasty under spinal anaesthesia (TKADEX)-a prospective, double-blinded, randomised controlled trial.

BJA Open . 2025 Mar 3:13:100382.

Contributing Authors:
SM Tiainen H Heinonen A Koskinen S Mäkelä R Laitio E Löyttyniemi K Mäkelä TI Saari P Uusalo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and one patients undergoing elective total knee arthroplasty under spinal anaesthesia were randomized to receive either intranasal dexmedetomidine (n=49) or intranasal saline placebo (n=52). The primary outcome was postoperative pain measured using the numerical rating scale (NRS) during the first 24 hours. Secondary outcomes included postoperative opioid requirements, additional intra...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue